NCT06279767 2024-02-28
Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma
The First Affiliated Hospital with Nanjing Medical University
Phase 1/2 Unknown
The First Affiliated Hospital with Nanjing Medical University
FDA Office of Orphan Products Development